T · 7079.T
WDB coco Co., Ltd.
- Sector
- Healthcare · Drug Manufacturers - Specialty & Generic
- Headquarters
- Tokyo 104-6127
- Website
- wdbcoco.com
Price · as of 2025-03-31
$2,618.00
Market cap 6.61B
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $3,521.85 | +34.52% |
| Intrinsic Value(DCF) | $2,309.90 | -11.77% |
| Graham-Dodd Method(GD) | $2,508.54 | -4.18% |
| Graham Formula(GF) | $8,895.97 | +239.8% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | $2,646.07 | ||||
| 2021 | $3,600.34 | $2,470.62 | $5,985.94 | $993.47 | $3,291.90 |
| 2022 | $4,800.63 | $2,937.00 | $149,546.00 | $1,753.80 | $12,865.68 |
| 2023 | $5,217.41 | $3,765.61 | $17,249.64 | $2,129.63 | $6,281.64 |
| 2024 | $3,370.01 | $3,128.61 | $15,284.95 | $2,596.34 | $7,339.76 |
| 2025 | $2,983.00 | $3,521.85 | $12,311.06 | $2,508.54 | $8,895.97 |
AI valuation
Our deep-learning model estimates WDB coco Co., Ltd.'s (7079.T) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $3,521.85
- Current price
- $2,618.00
- AI upside
- +34.52%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$2,309.90
-11.77% upside
Graham-Dodd
$2,508.54
-4.18% upside
Graham Formula
$8,895.97
+239.8% upside
About WDB coco Co., Ltd.
WDB coco Co., Ltd. provides contract services to pharmaceutical companies in Japan. The company supports the development of pharmaceuticals and medical devices with a focus on safety information management; safety information management support; clinical research support; and post-marketing safety information management operations services. It also provides support for the preparation of various translation, and QC; clinical research support; and manpower dispatch services. In addition, the company offers post-marketing surveillance (PMS) services, such as contract conclusion with medical facilities, survey explanations, receipt of survey forms, monitoring services, including conducting re-surveys, case registration center, data management, and statistical analysis. WDB coco Co., Ltd. was incorporated in 1984 and is headquartered in Tokyo, Japan.
- CEO
- Haruhiko Taniguchi
- Employees
- 504
- Beta
- 0.11
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($2,309.90 ÷ $2,618.00) − 1 = -11.77% (DCF, example).